COVID-19; and High Infection Risk of SARS-CoV-2
1 clinical trials · Condition
◉ Watch COVID-19; and High Infection Risk of SARS-CoV-2
| Record | Firm | Date |
|---|---|---|
| Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects (NCT04441918) | Shanghai Junshi Bioscience Co., Ltd. | 2020-06-05 |
Track COVID-19; and High Infection Risk of SARS-CoV-2 automatically
Every clearance here is in the API, with alerts when new ones post.